Cargando…
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217500/ https://www.ncbi.nlm.nih.gov/pubmed/34155209 http://dx.doi.org/10.1038/s41467-021-24123-7 |
_version_ | 1783710602737221632 |
---|---|
author | Tan, Timothy J. C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. |
author_facet | Tan, Timothy J. C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. |
author_sort | Tan, Timothy J. C. |
collection | PubMed |
description | Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2. |
format | Online Article Text |
id | pubmed-8217500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82175002021-07-09 Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain Tan, Timothy J. C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. Nat Commun Article Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2. Nature Publishing Group UK 2021-06-21 /pmc/articles/PMC8217500/ /pubmed/34155209 http://dx.doi.org/10.1038/s41467-021-24123-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tan, Timothy J. C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title_full | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title_fullStr | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title_full_unstemmed | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title_short | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain |
title_sort | sequence signatures of two public antibody clonotypes that bind sars-cov-2 receptor binding domain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217500/ https://www.ncbi.nlm.nih.gov/pubmed/34155209 http://dx.doi.org/10.1038/s41467-021-24123-7 |
work_keys_str_mv | AT tantimothyjc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT yuanmeng sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT kuzelkakaylee sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT padrongilbertoc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT bealjacobr sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT chenxin sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT wangyiquan sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT riveracardonajoel sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT zhuxueyong sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT stadtmuellerbethm sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT brookechristopherb sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT wilsoniana sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain AT wunicholasc sequencesignaturesoftwopublicantibodyclonotypesthatbindsarscov2receptorbindingdomain |